Level B· Emerging clinical evidence with positive signalsRandomized Controlled TrialPubMed

Resveratrol pretreatment improved the function of mesenchymal stem cells in the recovery of spinal cord injury by stimulating the secretion of nerve growth factor.

Salimi A., Salarinia R., Bibak B., Ahmadpour S., Seddigh A., Forqani MA.

Randomized Controlled Trial on Spinal Cord Injury, published in J Mol Histol (2025) — summary generated from the PubMed abstract.

Open my reading list
Level B· Emerging clinical evidence with positive signalsEvidence level of this study

Several human studies show positive signals, while research methods and sample sizes continue to develop.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Randomized Controlled Trial
Journal
J Mol Histol (2025)
Country
Netherlands
Reported sample size
—
Source database
PubMed
PMID
40753358
DOI
10.1007/s10735-025-10541-0

Abstract (original English)

Depending on its severity, spinal cord injury (SCI) can cause bowel and bladder incontinence, sensory abnormalities, muscle paralysis, and lifelong disability. Enhancing the biological properties of stem cells before transplantation can improve the efficacy of cell therapy. Resveratrol has recently been used to enhance mesenchymal stem cells' (MSCs') paracrine capacity for tissue repair. Our goal was to implant mesenchymal stem cells (MSCs) into a rat spinal cord injury (SCI) model after pre-treating them with resveratrol. First, MSCs were isolated from adipose tissue. Then, the cells were treated with resveratrol, and the amount of nerve growth factor (NGF) in the supernatant was measured. Rats were randomly assigned to four groups and given a weight-drop technique to cause spinal cord injury. MSCs were injected into the site of injury 30 min after SCI. A functional recovery test was conducted over four weeks. Luxal fast blue and hematoxylin-eosin staining were done to evaluate the tissues. The concentration of 0.2 micromolar of resveratrol increased the expression of NGF in the supernatant of MSCs. There was a significant increase in the average motor function scores in the fourth week after the injury in animals that received stem cells treated with resveratrol compared to the SCI group. This study demonstrated that transplanted MSCs treated with resveratrol exhibit better e

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Several human studies show positive signals, while research methods and sample sizes continue to develop.

How we grade evidence
AnimalsResveratrolSpinal Cord InjuriesMesenchymal Stem CellsMesenchymal Stem Cell TransplantationNerve Growth FactorRecovery of FunctionRatsStilbenesRats, Sprague-Dawley

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research